See Recent Shionogi-Sponsored Congress Presentations

Congresses

As part of our commitment to addressing unmet medical needs, Shionogi continues to investigate approved products and pipeline compounds. Shionogi presents its research at major congress events globally.

The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

Select a congress event or filter to view available congress presentations.

  • All
  • APCCMI
  • ASCP
  • ASM Microbe
  • AVG and IMRP
  • CROI
  • ESCMID
  • GSA
  • IAS
  • IDWeek
  • ISIRV
  • NACFC
  • SCCM
  • All
  • 2025
  • 2024
  • All
  • COVID-19
  • Gram-negative infection
  • Respiratory Syncytial Virus (RSV)
  • All
  • Cefiderocol
  • Ensitrelvir
  • S-337395
  • S-892216
  • Xeruborbactam
  • All
  • Oral presentation
  • Poster presentation

You Are Viewing Presentations

IDWeek 2024
Cefiderocol

Activity of cefiderocol against carbapenem non-susceptible Enterobacterales, including molecularly characterized multidrug-resistant clinical isolates causing infections in United States hospitals (2020–2023)

View/Download Presentation
IDWeek 2024
Cefiderocol

Activity of cefiderocol and comparator agents against global Isolates of Stenotrophomonas maltophilia from the SENTRY Antimicrobial Surveillance Program (2020–2023)

View/Download Presentation
IDWeek 2024
Ensitrelvir

Analysis of post COVID-19 condition after ensitrelvir treatment in asymptomatic or mild-symptoms only patients in the SCORPIO phase2b/3 Study

View/Download Presentation
IDWeek 2024
Cefiderocol

Cefiderocol activity against carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex, including molecularly characterized cinical isolates, causing infections in United States hospitals (2020–2023)

View/Download Presentation
IDWeek 2024
Cefiderocol

Cefiderocol activity against clinical Enterobacterales isolates carrying metallo-β-lactamase genes in United States and European Hospitals (2020–2023) 

View/Download Presentation
IDWeek 2024
Cefiderocol

Cefiderocol activity against Pseudomonas aeruginosa clinical isolates carrying metallo-β-lactamase genes in United States and European Hospitals (2020–2023)

View/Download Presentation

You Are Viewing Congress Locations